Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma.

abstract：:The standard systemic treatment for prostate cancer (PCa) is androgen ablation, which causes tumor regression by inhibiting activity of the androgen receptor (AR). Invariably, PCa recurs with a fatal androgen-refractory phenotype. Importantly, the growth of androgen-refractory PCa remains dependent on the AR through v...

journal_title：Cancer research

authors： Dehm SM,Schmidt LJ,Heemers HV,Vessella RL,Tindall DJ

更新日期：2008-07-01 00:00:00

abstract：:LIGHT, a ligand for the lymphotoxin-beta receptor, establishes lymphoid-like tissues inside tumor sites and recruits naïve T cells into the tumor. However, whether these infiltrating T cells are specific for tumor antigens is not known. We hypothesized that therapy with LIGHT can expand functional tumor-specific CD8(+...

journal_title：Cancer research

authors： Kanodia S,Da Silva DM,Karamanukyan T,Bogaert L,Fu YX,Kast WM

更新日期：2010-05-15 00:00:00

abstract：:An orthotopic human lung cancer model in nu/nu mice was used to study the effect of an antisense K-ras (AS-K-ras) retroviral construct on tumor growth in vivo. A 2-kilobase genomic AS-K-ras DNA fragment linked to a beta-actin promoter was cloned into the LNSX retroviral vector. The recombinant construct was packaged i...

journal_title：Cancer research

authors： Georges RN,Mukhopadhyay T,Zhang Y,Yen N,Roth JA

更新日期：1993-04-15 00:00:00

abstract：:This study investigates whether and to what extent cyclooxygenase type-2 (COX-2) and inducible nitric oxide-synthase (iNOS), both known to have an immunosuppressive effect, are expressed in human ovarian tumors. Because COX-2 and iNOS can be expressed by activated macrophages, the presence of tumor-associated macropha...

journal_title：Cancer research

authors： Klimp AH,Hollema H,Kempinga C,van der Zee AG,de Vries EG,Daemen T

更新日期：2001-10-01 00:00:00

abstract：:The purpose of this research was to quantitate and confirm the mechanism of in vivo metabolic activation of temozolomide. The secondary aims were to evaluate the tumor, normal tissue, and plasma pharmacokinetics of temozolomide in vivo, and to determine whether such pharmacokinetics resulted in tumor targeting. [(11)C...

journal_title：Cancer research

authors： Saleem A,Brown GD,Brady F,Aboagye EO,Osman S,Luthra SK,Ranicar AS,Brock CS,Stevens MF,Newlands E,Jones T,Price P

更新日期：2003-05-15 00:00:00

abstract：:Polycyclic aromatic hydrocarbons, possible human breast carcinogens, are metabolized by cytochrome P4501A1 (CYP1A1) and glutathione S-transferase (GSTM1). A CYP1A1 polymorphism (isoleucine to valine substitution in exon 7) or the null allele for GSTM1 may affect the mutagenic potential of polycyclic aromatic hydrocarb...

journal_title：Cancer research

authors： Ambrosone CB,Freudenheim JL,Graham S,Marshall JR,Vena JE,Brasure JR,Laughlin R,Nemoto T,Michalek AM,Harrington A

更新日期：1995-08-15 00:00:00

abstract：:One hundred eighty-four cases of feline leukemia and lymphoma diagnosed in Boston from 1972 through 1976 were investigated. Fifty-eight % of these cases were lymphoma, and 42% were leukemia. Sixty-seven % of the cats had positive fluorescent antibody tests for circulating feline leukemia virus. The rest (33%) were vir...

journal_title：Cancer research

authors： Francis DP,Cotter SM,Hardy WD Jr,Essex M

更新日期：1979-10-01 00:00:00

abstract：:Previous work in our laboratory has demonstrated that antisera to proteins found in the urine of bladder cancer patients can distinguish between urine samples from these patients and those from normal individuals when tested by a complement-fixation assay. Antisera which were reactive with individual tumor-associated ...

journal_title：Cancer research

authors： De Fazio SR,Gozzo JJ,Monaco AP

更新日期：1982-07-01 00:00:00

abstract：:B7 coregulatory ligands can be aberrantly expressed in human disease. In the context of cancer, these ligands may act as antigen-specific inhibitors of T-cell-mediated antitumoral immunity. We recently reported that B7-H1 expression by carcinomas of the kidney and bladder portends aggressive disease and diminished sur...

journal_title：Cancer research

authors： Roth TJ,Sheinin Y,Lohse CM,Kuntz SM,Frigola X,Inman BA,Krambeck AE,McKenney ME,Karnes RJ,Blute ML,Cheville JC,Sebo TJ,Kwon ED

更新日期：2007-08-15 00:00:00

abstract：:We have previously shown that N-cadherin expression is associated with tumor invasion, and that some cancer cells respond to specific extracellular matrix molecules by up-regulating N-cadherin. Pancreatic cancer is characterized by excessive deposition of type I collagen. Here, we show that human pancreatic cancer cel...

journal_title：Cancer research

authors： Shintani Y,Hollingsworth MA,Wheelock MJ,Johnson KR

更新日期：2006-12-15 00:00:00

abstract：:The Fas receptor ligand FasL regulates immune cell levels by inducing apoptosis of Fas receptor-positive cells. Here, we studied the impact of host FasL on tumor development in mice. Genetically targeting FasL in naïve mice increased myeloid cell populations, but, in marked contrast, it reduced the levels of myeloid-d...

journal_title：Cancer research

authors： Peyvandi S,Buart S,Samah B,Vétizou M,Zhang Y,Durrieu L,Polrot M,Chouaib S,Benihoud K,Louache F,Karray S

更新日期：2015-10-15 00:00:00

abstract：:A structure-activity relationship study was carried out to identify structural features in arylalkyl and alkyl isothiocyanates that are associated with the inhibitory potency of these compounds against lung tumorigenesis induced in A/J mice by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-buta...

journal_title：Cancer research

authors： Jiao D,Eklind KI,Choi CI,Desai DH,Amin SG,Chung FL

更新日期：1994-08-15 00:00:00

abstract：:The Wilms' tumor 1 gene (WT1) encodes a transcription factor involved in cell growth and development. As we previously reported, WT1 expression is hardly detectable in normal hepatic tissue but is induced in liver cirrhosis. Although WT1 has been found to be overexpressed in a number of malignancies, the role of WT1 i...

journal_title：Cancer research

authors： Perugorria MJ,Castillo J,Latasa MU,Goñi S,Segura V,Sangro B,Prieto J,Avila MA,Berasain C

更新日期：2009-02-15 00:00:00

abstract：:Nuclear receptors are critical regulators of many physiological processes and have been shown to be involved in a variety of disease processes, including malignant neoplasms. Our laboratory is investigating the function of the retinoid-related orphan receptor gamma (RORgamma) and its possible role in disease. Studies ...

journal_title：Cancer research

authors： Ueda E,Kurebayashi S,Sakaue M,Backlund M,Koller B,Jetten AM

更新日期：2002-02-01 00:00:00

abstract：:Although accumulating evidence indicates that chronic lymphocytic leukemia (CLL) is a disease with appreciable cell dynamics, it remains uncertain whether this also applies to patients with stable disease. In this study, (2)H(2)O was administered to a clinically homogeneous cohort of nine stable, untreated CLL patient...

journal_title：Cancer research

authors： van Gent R,Kater AP,Otto SA,Jaspers A,Borghans JA,Vrisekoop N,Ackermans MA,Ruiter AF,Wittebol S,Eldering E,van Oers MH,Tesselaar K,Kersten MJ,Miedema F

更新日期：2008-12-15 00:00:00

abstract：:Multiple myeloma is a cytogenetically/molecularly heterogeneous hematologic malignancy that remains mostly incurable, and the identification of a universal and relevant therapeutic target molecule is essential for the further development of therapeutic strategy. Herein, we identified that 3-phosphoinositide-dependent ...

journal_title：Cancer research

authors： Chinen Y,Kuroda J,Shimura Y,Nagoshi H,Kiyota M,Yamamoto-Sugitani M,Mizutani S,Sakamoto N,Ri M,Kawata E,Kobayashi T,Matsumoto Y,Horiike S,Iida S,Taniwaki M

更新日期：2014-12-15 00:00:00

abstract：:The majority of patients with colon cancer will develop advanced disease, with the liver being the most common site of metastatic disease. Patients with increased numbers of tumor-infiltrating lymphocytes in primary colon tumors and liver metastases have improved outcomes. However, the molecular factors that could emp...

journal_title：Cancer research

authors： Qiao G,Qin J,Kunda N,Calata JF,Mahmud DL,Gann P,Fu YX,Rosenberg SA,Prabhakar BS,Maker AV

更新日期：2017-04-15 00:00:00

abstract：:Because of its relatively indolent clinical course, chronic lymphocytic leukemia (CLL) offers a versatile model for testing novel therapeutic regimens and drug combinations. Nicotinamide is the main NAD(+) precursor and a direct inhibitor of four classes of enzymes, including the sirtuins. SIRT1, the main member of th...

journal_title：Cancer research

authors： Audrito V,Vaisitti T,Rossi D,Gottardi D,D'Arena G,Laurenti L,Gaidano G,Malavasi F,Deaglio S

更新日期：2011-07-01 00:00:00

abstract：:Oncogenic KRAS mutations occur frequently in lung adenocarcinoma. The signaling pathways activated by IL6 promote Kras-driven lung tumorigenesis, but the basis for this cooperation is uncertain. In this study, we used the gp130(F/F) (Il6st) knock-in mouse model to examine the pathogenic contribution of hyperactivation...

journal_title：Cancer research

authors： Brooks GD,McLeod L,Alhayyani S,Miller A,Russell PA,Ferlin W,Rose-John S,Ruwanpura S,Jenkins BJ

更新日期：2016-02-15 00:00:00

abstract：:Microsomal epoxide hydrolase (mEH) is involved in the metabolism of tobacco-derived carcinogens. Polymorphisms in exons 3 and 4 of the EPHX gene have been reported to be associated with variations in mEH activity. We examined whether the predicted mEH activity modified the lung cancer risk among 150 cases and 172 cont...

journal_title：Cancer research

authors： Benhamou S,Reinikainen M,Bouchardy C,Dayer P,Hirvonen A

更新日期：1998-12-01 00:00:00

abstract：:The human colon cancer cell line HCT does not express any detectable HLA class I antigens on the cell surface. RNA blot analyses showed that HCT cells synthesize easily detectable levels of heavy chains as well as beta 2-microglobulin (beta 2m) transcripts. Experiments of immunoprecipitation revealed the presence of i...

journal_title：Cancer research

authors： Gattoni-Celli S,Kirsch K,Timpane R,Isselbacher KJ

更新日期：1992-03-01 00:00:00

abstract：:The secretion of transforming growth factors (TGFs) alpha and beta by normal, chemically transformed, and malignant rat liver epithelial cell lines was investigated. The WB-F344 normal cultured rat liver epithelial cell line does not secrete an epidermal growth factor-like (putatively TGF-alpha) activity, but several ...

journal_title：Cancer research

authors： Liu C,Tsao MS,Grisham JW

更新日期：1988-02-15 00:00:00

abstract：:The tumor localization of various anti-CD5 immunotoxins (ITs) was studied in vivo in BALB/c nude mice bearing human ascitic Ichikawa tumor cells. Plasma and ascitic clearance of IT as well as the number of intact IT molecules taken up per tumor cell was measured with a highly sensitive immunoenzymometric assay. This a...

journal_title：Cancer research

authors： Rostaing-Capaillon O,Casellas P

更新日期：1990-05-15 00:00:00

abstract：:The relative amounts of HLA-A,B,C antigens, beta 2-microglobulin (beta 2m), and trophoblast antigens (Trop-1 and Trop-2) were determined on nine choriocarcinoma cell lines including seven lines of gestational origin and two lines of nongestational origin (from ovary and stomach) by quantitative immunofluorescence anal...

journal_title：Cancer research

authors： Kawata M,Sizer K,Sekiya S,Parnes JR,Herzenberg LA

更新日期：1984-09-01 00:00:00

abstract：:We have recently found that human pancreatic adenocarcinomas exhibit strong immunostaining for the three mammalian transforming growth factor beta (TGF-beta) isoforms. These important growth-regulating polypeptides bind to a number of proteins, including the type I TGF-beta receptor (T beta R-I), type II TGF-beta rece...

journal_title：Cancer research

authors： Friess H,Yamanaka Y,Büchler M,Berger HG,Kobrin MS,Baldwin RL,Korc M

更新日期：1993-06-15 00:00:00

abstract：:We conducted a case-control study of estrogen receptor (ER) and progesterone receptor (PgR) expression in benign breast epithelium from 120 women (51 breast cancer cases and 69 benign disease controls) who underwent breast operations at University Hospital, Syracuse, New York. Benign samples were obtained and processe...

journal_title：Cancer research

authors： Khan SA,Rogers MA,Obando JA,Tamsen A

更新日期：1994-02-15 00:00:00

abstract：:Photodynamic therapy (PDT) treatment of murine EMT6 mammary sarcoma using Photofrin (10 mg/kg) and light (110 J/cm2) cured all these lesions growing in syngeneic BALB/c mice. In contrast, the same treatment produced initial ablation but no long-term cures of EMT6 tumors growing in either scid or nude mice, the immunod...

journal_title：Cancer research

authors： Korbelik M,Krosl G,Krosl J,Dougherty GJ

更新日期：1996-12-15 00:00:00

abstract：:The cyclin dependent kinase (CDK) inhibitors p15, p16, p21, and p27 are frequently deleted, silenced, or downregulated in many malignancies. Inactivation of CDK inhibitors predisposes mice to tumor development, showing that these genes function as tumor suppressors. Here, we describe high-throughput murine leukemia vi...

journal_title：Cancer research

authors： Kool J,Uren AG,Martins CP,Sie D,de Ridder J,Turner G,van Uitert M,Matentzoglu K,Lagcher W,Krimpenfort P,Gadiot J,Pritchard C,Lenz J,Lund AH,Jonkers J,Rogers J,Adams DJ,Wessels L,Berns A,van Lohuizen M

更新日期：2010-01-15 00:00:00

abstract：:The expression of the major glycoprotein, gp71, of murine leukemia virus was studied on the surfaces of a variety of normal murine cell lines with a monospecific rabbit antiserum raised against purified Friend murine leukemia virus gp71. Using viable cell membrane immunofluorescence, most established and early passage...

journal_title：Cancer research

authors： Cloyd MW,Bolognesi DP,Bigner DD

更新日期：1977-03-01 00:00:00

abstract：:alpha-Difluoromethylornithine (DFMO), an enzyme-activated irreversible inhibitor of ornithine decarboxylase (ODC), was used to select two very highly drug-resistant cell lines, designated K562-DFMOr and V79-DFMOr. Both DFMO-resistant cell lines exhibited elevated ODC expression due to gene amplification. Moreover, the...

journal_title：Cancer research

authors： Ask A,Persson L,Rehnholm A,Frostesjö L,Holm I,Heby O

更新日期：1993-11-01 00:00:00